Immunohistochemistry (IHC) revealed that the expression of COL4A2 in tumor tissue was significantly greater than normal (Fig. 2G), and COL4A2 was divided into high and low-expression (Fig. 2G). This evidence concerns the gene COL4A2 and neoplasm.